publication date: Nov. 8, 2013

Max Wicha to Leave Director’s Job at the University of Michigan The Cancer Letter’s Conversation with Wicha BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor Penberthy Named NCI DCCPS Associate Director For Surveillance Research Yervoy Granted European Approval As First-Line Melanoma Therapy

Download the PDF

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.